<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McCall SJ</submitter><funding>Medical Research Council</funding><funding>University of Kentucky</funding><funding>French Health Ministry under its Clinical Research Hospital Program</funding><pagination>1676-1685</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9544707</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>129(10)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To compare the management and outcomes of women with placenta accreta spectrum (PAS) in France and the UK.&lt;h4>Design&lt;/h4>Two population-based cohorts.&lt;h4>Setting&lt;/h4>All obstetrician-led hospitals in the UK and maternity hospitals in eight French regions.&lt;h4>Population&lt;/h4>A cohort of 219 women with PAS in France and a cohort of 154 women with PAS in the UK.&lt;h4>Methods&lt;/h4>The management and outcomes of women with PAS were compared between the UK and France.&lt;h4>Main outcome measures&lt;/h4>Median blood loss, severe postpartum haemorrhage (≥3 l), postpartum infection and damage to surrounding organs.&lt;h4>Results&lt;/h4>The management of PAS differed between the two countries: a larger proportion of women with PAS in the UK had a caesarean hysterectomy compared with France (43% vs 26%, p &lt; 0.001), whereas in France a larger proportion of women with PAS received a uterus-preserving approach compared with the UK (36% vs 19%, p &lt; 0.001). The total median blood loss in the UK was 3 l (IQR 1.7-6.5 l), compared with 1 l (IQR 0.5-2.5 l) in France; more women with PAS had a severe postpartum haemorrhage (PPH) in the UK compared with women with PAS in France (58% vs 21%, p &lt; 0.001) [Correction added on 06 May 2022, after first online publication: '24 hour' has been changed to 'total' in the preceding sentence]. There was no difference between the UK and French populations for postpartum infection or organ damage.&lt;h4>Conclusions&lt;/h4>The UK and France have very different approaches to managing PAS, with more women in France receiving a uterine-conserving approach and more women in the UK undergoing caesarean hysterectomy. A life-threatening haemorrhage was more common in the UK than in France, which may be the result of differential management and/or the organisation of the healthcare systems. In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France.&lt;h4>Tweetable abstract&lt;/h4>In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France.</pubmed_abstract><journal>BJOG : an international journal of obstetrics and gynaecology</journal><pubmed_title>Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.</pubmed_title><pmcid>PMC9544707</pmcid><funding_grant_id>AOR12156</funding_grant_id><pubmed_authors>Kayem G</pubmed_authors><pubmed_authors>Collins SL</pubmed_authors><pubmed_authors>Kurinczuk JJ</pubmed_authors><pubmed_authors>Knight M</pubmed_authors><pubmed_authors>Sentilhes L</pubmed_authors><pubmed_authors>McCall SJ</pubmed_authors><pubmed_authors>Ramakrishnan R</pubmed_authors><pubmed_authors>Deneux-Tharaux C</pubmed_authors><pubmed_authors>Seco A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.</name><description>&lt;h4>Objective&lt;/h4>To compare the management and outcomes of women with placenta accreta spectrum (PAS) in France and the UK.&lt;h4>Design&lt;/h4>Two population-based cohorts.&lt;h4>Setting&lt;/h4>All obstetrician-led hospitals in the UK and maternity hospitals in eight French regions.&lt;h4>Population&lt;/h4>A cohort of 219 women with PAS in France and a cohort of 154 women with PAS in the UK.&lt;h4>Methods&lt;/h4>The management and outcomes of women with PAS were compared between the UK and France.&lt;h4>Main outcome measures&lt;/h4>Median blood loss, severe postpartum haemorrhage (≥3 l), postpartum infection and damage to surrounding organs.&lt;h4>Results&lt;/h4>The management of PAS differed between the two countries: a larger proportion of women with PAS in the UK had a caesarean hysterectomy compared with France (43% vs 26%, p &lt; 0.001), whereas in France a larger proportion of women with PAS received a uterus-preserving approach compared with the UK (36% vs 19%, p &lt; 0.001). The total median blood loss in the UK was 3 l (IQR 1.7-6.5 l), compared with 1 l (IQR 0.5-2.5 l) in France; more women with PAS had a severe postpartum haemorrhage (PPH) in the UK compared with women with PAS in France (58% vs 21%, p &lt; 0.001) [Correction added on 06 May 2022, after first online publication: '24 hour' has been changed to 'total' in the preceding sentence]. There was no difference between the UK and French populations for postpartum infection or organ damage.&lt;h4>Conclusions&lt;/h4>The UK and France have very different approaches to managing PAS, with more women in France receiving a uterine-conserving approach and more women in the UK undergoing caesarean hysterectomy. A life-threatening haemorrhage was more common in the UK than in France, which may be the result of differential management and/or the organisation of the healthcare systems. In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France.&lt;h4>Tweetable abstract&lt;/h4>In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-22T12:13:04.793Z</modification><creation>2025-04-06T00:15:20.052Z</creation></dates><accession>S-EPMC9544707</accession><cross_references><pubmed>35384244</pubmed><doi>10.1111/1471-0528.17169</doi></cross_references></HashMap>